Viewing Study NCT01145495

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 2:06 PM

Ignite Modification Date: 2025-12-27 @ 10:39 PM

Study NCT ID: NCT01145495

Status: COMPLETED

Last Update Posted: 2023-06-27

First Post: 2010-06-15

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Sponsor: National Cancer Institute (NCI)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module